CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has announced a significant milestone: they have de-risked over 1000 clinical studies. With over 6,000 platform users and more than 100,000 issues detected, CluePoints is proud to have been an integral player in the adoption of Risk-Based Monitoring (RBM) and later […]

The post RBQM Market Leader, CluePoints, Celebrates Milestone of De-risking 1000 Clinical Studies first appeared on World Pharma Today.